Global corporate AI investment reached $489.6 billion in 2025, up approximately 124% from $218.6 billion in 2024, as generative AI commercialization, hyperscaler infrastructure spending and sovereign AI programs accelerated, BCC Research said. Global private AI investment alone rose 122% to $290.1 billion. The report, Global AI Investment Trends & Spending Outlook, highlights Anthropic's May 2026 Series H, which raised $65 billion at a $965 billion post-money valuation with run-rate revenue exceeding $47 billion, and OpenAI's valuation increase from approximately $20 billion in 2022 to $852 billion by March 2026. Alphabet has guided 2026 capital expenditure to $180 billion-$190 billion, while Microsoft is expected to invest approximately $190 billion. OpenAI has contracted $300 billion in computing power from Oracle over roughly five years, and AWS and OpenAI agreed to a multi-year strategic partnership valued at $38 billion in November 2025. The United States remains the leading market for private investment and federal AI spending, while France, Saudi Arabia and China are developing major sovereign programs. BCC Research also points to breakout financing in physical AI, humanoid robotics and defense, alongside expanding applications in pharmaceuticals, automotive and drug discovery. The report says the investment surge reflects a structural reconfiguration rather than a cyclical boom, but warns that chip supply, export restrictions, electricity demand, grid constraints, valuation risk, talent shortages, regulatory uncertainty and Europe's investment gap could limit returns. The update builds on BCC Research's AI Use Case Analysis: Global Outlook, which described AI as moving into core economic infrastructure across healthcare, finance, retail, telecom, government and manufacturing. That report highlighted generative, multimodal, agentic, quantum and physical AI, including drug discovery, cybersecurity, semiconductor manufacturing and enterprise platforms, while identifying implementation barriers and long quantum commercialization timelines.